United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

teva uk ltd - tamoxifen citrate - oral tablet - 20mg

Ireland - English - HPRA (Health Products Regulatory Authority)

rosemont pharmaceuticals ltd - tamoxifen citrate - oral solution - 10 mg/5ml - anti-estrogens; tamoxifen

Ireland - English - HPRA (Health Products Regulatory Authority)

generics (uk) limited - tamoxifen citrate - tablets - 20 milligram - tamoxifen

Malta - English - Medicines Authority

wockhardt uk limited ash road north, wrexham, ll13 9uf, united kingdom - tamoxifen - film-coated tablet - tamoxifen 10 mg - endocrine therapy

Malta - English - Medicines Authority

wockhardt uk limited ash road north, wrexham, ll13 9uf, united kingdom - tamoxifen - film-coated tablet - tamoxifen 20 mg - endocrine therapy

Ireland - English - HPRA (Health Products Regulatory Authority)

perrigo pharma international designated activity company - tamoxifen citrate - oral solution - 10 mg/5ml - anti-estrogens; tamoxifen

New Zealand - English - Medsafe (Medicines Safety Authority)

sandoz new zealand limited - tamoxifen citrate 15.2mg equivalent to tamoxifen 10 mg;   - film coated tablet - 10 mg - active: tamoxifen citrate 15.2mg equivalent to tamoxifen 10 mg   excipient: hypromellose lactose monohydrate   macrogol 4000 magnesium stearate microcrystalline cellulose povidone sodium starch glycolate titanium dioxide

New Zealand - English - Medsafe (Medicines Safety Authority)

sandoz new zealand limited - tamoxifen citrate 30.4mg equivalent to tamoxifen 20 mg;   - film coated tablet - 20 mg - active: tamoxifen citrate 30.4mg equivalent to tamoxifen 20 mg   excipient: hypromellose lactose monohydrate   macrogol 4000 magnesium stearate microcrystalline cellulose povidone sodium starch glycolate titanium dioxide

Australia - English - Department of Health (Therapeutic Goods Administration)

southern cross pharma pty ltd - tamoxifen citrate, quantity: 30.34 mg (equivalent: tamoxifen, qty 20 mg) - tablet - excipient ingredients: lactose monohydrate; maize starch; magnesium stearate; brilliant scarlet 4r; povidone - treatment of breast cancer tamoxifen lupin is indicated for the treatment of breast cancer.,primary reduction of breast cancer risk tamoxifen lupin is indicated for the primary reduction of breast cancer risk in women either at moderately increased risk (lifetime breast cancer risk 1.5 to 3 times the population average) or high risk (lifetime breast cancer risk greater than 3 times the population average).

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

a a h pharmaceuticals ltd - tamoxifen citrate - oral tablet - 20mg